Us Bancorp »

Catalyst Pharmaceutical Partners shares owned by Us Bancorp

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-03-31 $773k 49k 15.94
2023-12-31 $1.1M 65k 16.81
2023-09-30 $465k 40k 11.69
2023-06-30 $614k 46k 13.44
2023-03-31 $624k 38k 16.58
2022-12-31 $2.1k 112 18.60
2022-09-30 $1.0k 100 10.00
2022-06-30 $1.0k 100 10.00
2022-03-31 $1.0k 100 10.00

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Ishares Tr Rus Mid Cap Etf (IWR)
Eli Lilly & Co. (LLY)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
JPMorgan Chase & Co. (JPM)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Us Bancorp

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners